Fundz

LeonaBio Appoints Mark F. Kubik as Chief Business Officer

PUBLIC · LONAFeb 03, 2026

Position

Chief Business Officer

Company

LeonaBio, Inc.

Mark F. Kubik
BothellBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

LeonaBio, Inc. has announced the appointment of Mark F. Kubik as Chief Business Officer, effective February 1, 2026

Quick answer

LeonaBio Appoints Mark F. Kubik as Chief Business Officer (February 3, 2026). LeonaBio, Inc. is based in Bothell, Washington, United States.

Who is the new Chief Business Officer at LeonaBio, Inc?
LeonaBio, Inc. named Mark F. Kubik Chief Business Officer, announced February 3, 2026.
What did LeonaBio, Inc. announce on February 3, 2026?
LeonaBio, Inc. has announced the appointment of Mark F. Kubik as Chief Business Officer, effective February 1, 2026
What does LeonaBio, Inc. do?
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration.
Where is LeonaBio, Inc. based?
LeonaBio, Inc. is based in Bothell, Washington, United States.
Which similar companies made leadership changes around the same time?
Bicycle Therapeutics (February 3, 2026), Bristol Myers Squibb (February 9, 2026), Ocular Therapeutix (January 21, 2026) and Aquestive Therapeutics, Inc. (February 18, 2026) also announced leadership changes within 45 days of LeonaBio, Inc.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Pharmaceutical

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at LeonaBio, Inc., and when

A new leader at LeonaBio, Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day LeonaBio, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at LeonaBio, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at LeonaBio, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

LeonaBio, Inc.

Location

18706 N Creek Pkwy, Suite 104

Bothell, Washington, United States

About

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment LeonaBio, Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Javier
Likely contact at this company
••••••••@••••••••

See Javier's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for LeonaBio, Inc.'s next move

Learn about Strategic plan

LeonaBio, Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.